08045804946
medisus.pharma007@gmail.com
भाषा बदलें
Bendamustine Injection IP

Bendamustine Injection IP

उत्पाद विवरण:

  • संकेत Chronic lymphocytic leukemia (CLL), Non-Hodgkins lymphoma (NHL)
  • खुराक प्रपत्र Injection
  • नमक की संरचना Bendamustine Hydrochloride
  • फ़ीचर
  • सामग्रियां
  • एप्लीकेशन
  • भौतिक रंग/बनावट
  • अधिक देखने के लिए क्लिक करें
X

मूल्य और मात्रा

  • 5

उत्पाद की विशेषताएं

  • 2 years
  • Store below 25°C, protect from light
  • Chronic lymphocytic leukemia (CLL), Non-Hodgkins lymphoma (NHL)
  • Bendamustine Hydrochloride
  • Injection

व्यापार सूचना

  • प्रति सप्ताह
  • दिन
  • , , , , , , , ,
  • , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

उत्पाद वर्णन

Bendit 100mg Injection is usedto treat cancer of the lymphatic system such as Non-Hodgkin's Lymphoma (NHL). It may also be used to treat other types of cancer as determined by your doctor. It can be used alone, or together with certain other medicines as part of combination chemotherapy.


  1. What is Bendamustine?

    • Bendamustine is a chemotherapy drug belonging to the class of alkylating agents. It works by interfering with the DNA structure of cancer cells, ultimately leading to their death.
  2. What is Bendamustine used for?

    • Bendamustine is used in the treatment of certain types of cancer, including CLL, NHL, and multiple myeloma. It is often used in combination with other chemotherapy medications or treatments.
  3. How is Bendamustine administered?

    • Bendamustine is typically administered as an intravenous (IV) infusion. The dosage and schedule of administration will depend on factors such as the type and stage of cancer being treated, as well as the individual patient's overall health and response to the medication.
  4. What are the common side effects of Bendamustine?

    • Common side effects of Bendamustine may include nausea, vomiting, diarrhea, constipation, fatigue, weakness, low blood cell counts (neutropenia, thrombocytopenia), and infusion site reactions. Some patients may also experience allergic reactions or infections.
  5. Are there any important precautions or interactions to be aware of?

    • Yes, there are several precautions and potential interactions to consider. Bendamustine may interact with other medications, so it's important to inform your healthcare provider about all medications, supplements, and herbal products you are taking. Additionally, Bendamustine can cause fetal harm, so it should not be used during pregnancy. It is also not recommended for use in breastfeeding women.
  6. How effective is Bendamustine in treating cancer?

    • Bendamustine has been shown to be effective in treating certain types of cancer, particularly CLL and NHL. It is often used when other treatments have not been successful or as part of a combination therapy regimen. The effectiveness of Bendamustine can vary depending on factors such as the type and stage of cancer and the individual patient's response to the medication.
  7. What should I do if I miss a dose of Bendamustine?

    • If you miss a dose of Bendamustine, it's important to contact your healthcare provider or infusion center as soon as possible to reschedule your appointment. It's essential to maintain the recommended treatment schedule to maximize the effectiveness of the medication.
  8. What should I expect during Bendamustine treatment?

    • During Bendamustine treatment, you may experience side effects such as nausea, fatigue, and low blood cell counts. Your healthcare provider will monitor your progress closely and may adjust your dosage or provide supportive care to help manage side effects. It's important to communicate any concerns or symptoms you experience with your healthcare team.

 



Targeted Cancer Therapy

Bendamustine Injection IP is designed for patients diagnosed with chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL). Its active compound, bendamustine hydrochloride, interrupts cancer cell growth, making it a valuable chemotherapeutic agent for suitable patients. FDA approval ensures its safety and efficacy for indicated uses.


Safe and Convenient Usage

Each vial is sterile, ready-to-use, and supplied for single use to minimize contamination risks. Before administration, it must be reconstituted with 0.9% Sodium Chloride and delivered as an intravenous infusion by healthcare professionals. Clear storage guidelines and prescription requirement help ensure safe handling and use.


Reliable Distribution

Bendamustine Injection IP is available through reputable distributors, suppliers, and exporters throughout India, ensuring consistent access for healthcare providers and patients. Packaging information, like batch number and MRP, can be found directly on the vial, maintaining transparency and traceability within the supply chain.

FAQ's of Bendamustine Injection IP:


Q: How should Bendamustine Injection IP be prepared and administered?

A: Bendamustine Injection IP must be reconstituted with a specified volume of 0.9% Sodium Chloride Injection and administered by intravenous infusion. The process should be carried out by a healthcare professional in a medical facility.

Q: What is Bendamustine Injection IP used for?

A: Bendamustine Injection IP is primarily indicated for the treatment of certain cancers, specifically chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL). It works as part of anti-cancer chemotherapy regimens.

Q: When is it necessary to use this medication?

A: This medication is prescribed when a patient has been diagnosed with CLL or NHL, and a healthcare provider determines it is an appropriate part of their treatment plan. The usage and dosage schedule is tailored to the individual patient's needs.

Q: Where should Bendamustine Injection IP be stored before use?

A: The vials should be stored below 25C and protected from light to preserve their efficacy and shelf life. Always keep the product in its original packaging until use.

Q: What are the disposal instructions for unused portions?

A: Any unused portion of Bendamustine Injection IP must be disposed of as per local regulations for hazardous pharmaceutical waste. Never reuse or store leftover solution.

Q: What are the key benefits of using Bendamustine Injection IP?

A: The primary benefit is its proven effectiveness in treating CLL and NHL by halting cancer cell proliferation. As an FDA-approved medication, it offers a reliable and standardized option for oncology treatment.

Q: Is a prescription required to obtain Bendamustine Injection IP?

A: Yes, Bendamustine Injection IP is a prescription-only medication. It must be administered and monitored by qualified healthcare professionals.

Tell us about your requirement
product

Price:  

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
मोबाइल number

Email

बेवाकिज़ुमैब इंजेक्शन अन्य उत्पाद



Back to top